With the advent of ‘Omicron’, a new strain of COVID-19, the demand for diagnostic kits is expected to increase significantly, and Seegene’s (096530) stock price is strong.
While stocks related to ‘Corona 19 (diagnostic kit)’ were showing strength on the 29th, Seegene also rose 9.6% from the previous day, and soared.
In addition to Seegene, Somagen (29.84%), Labgenomics (13.85%), and Sugentech (6.95%) are showing an upward trend in Corona 19 (diagnostic kit) related items.
‘Omicron’, designated as a new mutant virus by the World Health Organization (WHO) on the 26th, had 32 mutated genomes in its ‘spike protein’ on its surface, twice as many as the delta mutation.
Regarding Seegene, KTB Investment & Securities said △Reagent and equipment lock-in effect due to equipment sales △Increased use of multiplex technology due to increased demand for syndromic testing (symptom-based panel inspection) △Development of reagent development automation system (SGDDS) and mergers and acquisitions ( It is analyzed that the mid- to long-term driving force (momentum), such as entry into new businesses through M&A), will be effective.
Meanwhile, according to the Korea Centers for Disease Control and Prevention (KCDC) on the 28th, the cumulative number of confirmed COVID-19 cases in Korea increased by 3928 to 448,896 as of 00:00 on the same day.
This article was jointly written by Electronic Newspaper and Thinkpool, a financial AI specialist. This is an ‘AI Humanoid Article’ with the reporter’s coverage added to the AI-based data.
Reporter Min-ha Yang (mh.yang@etnews.com), Electronic Newspaper Internet
.
